Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples